Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Shock ; 62(1): 119-126, 2024 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-38662613

RESUMEN

ABSTRACT: Background : It is reported that circVMA21 has an inhibition effect on sepsis-induced acute kidney injury (AKI). Therefore, the underlying molecular mechanisms of circVMA21 in AKI are worthy of further investigation. Material and Methods : Lipopolysaccharide (LPS) was used to induce HK2 cell injury. CircVMA21, miR-337-3p and ZEB2 expression was tested by qRT-PCR. Cell growth was detected by CCK8 assay, EdU assay, and flow cytometry. Protein levels were examined by western blot. The levels of inflammatory factors and oxidative stress markers were measured to evaluate cell inflammatory response and oxidative stress. RNA relationship as verified by dual-luciferase reporter assay, RIP assay, and RNA pull-down assay. Results : CircVMA21 had decreased expression in AKI patients. Overexpressed circVMA21 alleviated LPS-induced HK2 cell inflammation, apoptosis, and oxidative stress. Moreover, circVMA21 sponged miR-337-3p, and miR-337-3p targeted ZEB2. The inhibitory effect of circVMA21 on LPS-induced HK2 cell injury was reversed by miR-337-3p overexpression, and ZEB2 overexpression abolished the promotion effect of miR-337-3p on LPS-induced HK2 cell injury. Conclusions : CircVMA21 could inhibit LPS-induced HK2 cell injury via miR-337-3p/ZEB2 axis.


Asunto(s)
Lesión Renal Aguda , Lipopolisacáridos , MicroARNs , ARN Circular , Caja Homeótica 2 de Unión a E-Box con Dedos de Zinc , Lipopolisacáridos/toxicidad , Humanos , Lesión Renal Aguda/metabolismo , Lesión Renal Aguda/patología , ARN Circular/genética , ARN Circular/metabolismo , MicroARNs/metabolismo , MicroARNs/genética , Caja Homeótica 2 de Unión a E-Box con Dedos de Zinc/metabolismo , Caja Homeótica 2 de Unión a E-Box con Dedos de Zinc/genética , Línea Celular , Estrés Oxidativo , Apoptosis/efectos de los fármacos
2.
Food Funct ; 6(11): 3454-63, 2015 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-26292622

RESUMEN

Ulcerative colitis is a major inflammatory bowel disease (IBD), characterized by inflammation within the gastrointestinal tract through chronic or relapsing immune system activation. The aim of this study is to investigate the potential protective effect of oat ß-glucan (ßG) against colitis induced by DSS in mice. Eighty mice were randomly divided into the control group (no DSS, no ßG), DSS group (DSS only), DSS + L-ßG group (DSS plus 500 mg per kg ßG), and DSS + H-ßG group (DSS plus 1000 mg per kg ßG). Compared with the DSS group, administration of ßG significantly reduced clinical symptoms with less weight loss, diarrhea and shortening of the colon, the severity of colitis was significantly inhibited as evidenced by the reduced disease activity index (DAI) and degree of histological damage in colon. Moreover, treatment with ßG not only decreased myeloperoxidase activity (MPO), and nitric oxide (NO) and malondialdehyde (MDA) levels, but also inhibited mRNA and protein expression of pro-inflammatory factors such as TNF-α, IL-1ß, IL-6 and iNOS. This suggests that oat ßG in diet might exhibit an anti-inflammatory function against colitis through inhibition of expression of pro-inflammatory factors.


Asunto(s)
Avena/química , Colitis Ulcerosa/tratamiento farmacológico , Fitoterapia , Sustancias Protectoras/administración & dosificación , beta-Glucanos/administración & dosificación , Animales , Antiinflamatorios no Esteroideos/administración & dosificación , Colitis Ulcerosa/inducido químicamente , Colitis Ulcerosa/patología , Colon/efectos de los fármacos , Colon/metabolismo , Colon/patología , Citocinas/metabolismo , Sulfato de Dextran , Diarrea/prevención & control , Masculino , Malondialdehído/metabolismo , Ratones , Ratones Endogámicos ICR , Óxido Nítrico/metabolismo , Peroxidasa/metabolismo , ARN Mensajero/metabolismo , Distribución Aleatoria , Bazo/efectos de los fármacos , Pérdida de Peso/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA